Dissecting the sCD3-CD4+ T-cell population: A valuable screening tool for angioimmunoblastic T-cell lymphoma

Cytometry B Clin Cytom. 2022 Mar;102(2):171-174. doi: 10.1002/cyto.b.22056. Epub 2022 Jan 21.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antigens, CD
  • Biomarkers, Tumor
  • CD4-Positive T-Lymphocytes / pathology
  • Flow Cytometry
  • Humans
  • Immunoblastic Lymphadenopathy* / diagnosis
  • Immunoblastic Lymphadenopathy* / pathology
  • Lymphoma, T-Cell* / diagnosis

Substances

  • Antigens, CD
  • Biomarkers, Tumor